A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor

被引:9
作者
Miao, Zheng [1 ]
Ren, Gang [1 ]
Jiang, Lei [1 ]
Liu, Hongguang [1 ]
Webster, Jack M. [2 ]
Zhang, Rong [2 ]
Namavari, Mohammad [1 ,3 ]
Gambhir, Sanjiv S. [1 ,3 ]
Syud, Faisal [2 ]
Cheng, Zhen [1 ]
机构
[1] Stanford Univ, Dept Radiol, Stanford Canc Ctr, MIPS,Bio X Program, Stanford, CA 94305 USA
[2] GE Co, Global Res, Niskayuna, NY 12309 USA
[3] Stanford Univ, Dept Bioengn, Stanford Canc Ctr, MIPS,Bio X Program, Stanford, CA 94305 USA
关键词
PET; HER2; F-18; Affibody; Scaffold protein; CYSTINE-KNOT PEPTIDES; AFFIBODY MOLECULES; RECEPTOR-BINDING; EXPRESSION;
D O I
10.1007/s00259-011-1879-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Two-helix scaffold proteins (similar to 5 kDa) against human epidermal growth factor receptor type 2 (HER2) have been discovered in our previous work. In this research we aimed to develop an F-18-labeled two-helix scaffold protein for positron emission tomography (PET) imaging of HER2-positive tumors. Methods An aminooxy-functionalized two-helix peptide (AO-MUT-DS) with high HER2 binding affinity was synthesized through conventional solid phase peptide synthesis. The purified linear peptide was cyclized by I-2 oxidation to form a disulfide bridge. The cyclic peptide was then conjugated with a radiofluorination synthon, 4-F-18-fluorobenzyl aldehyde (F-18-FBA), through the aminooxy functional group at the peptide N terminus (30% yield, non-decay corrected). The binding affinities of the peptides were analyzed by Biacore analysis. Cell uptake assay of the resulting PET probe, F-18-FBO-MUT-DS, was performed at 37A degrees C. F-18-FBO-MUT-DS with high specific activity (20-32 MBq/nmol, 88-140 mu Ci/mu g, end of synthesis) was injected into mice xenograft model bearing SKOV3 tumor. MicroPET and biodistribution and metabolic stability studies were then conducted. Results Cell uptake assays showed high and specific cell uptake (similar to 12% applied activity at 1 h) by incubation of F-18-FBO-MUT-DS with HER2 high-expressing SKOV3 ovarian cancer cells. The affinities (K-D) of AO-MUT-DS and FBO-MUT-DS as tested by Biacore analysis were 2 and 1 nM, respectively. In vivo small animal PET demonstrated fast tumor targeting, high tumor accumulation, and good tumor to normal tissue contrast of F-18-FBO-MUT-DS. Biodistribution studies further revealed that the probe had excellent tumor uptake (6.9%ID/g at 1 h post-injection) and was cleared through both liver and kidneys. Co-injection of the probe with 500 mu g of HER2 Affibody protein reduced the tumor uptake (6.9 vs 1.8%ID/g, p < 0.05). Conclusion F-FBO-MUT-DS displays excellent HER2 targeting ability and tumor PET imaging quality. The two-helix scaffold proteins are suitable for development of F-18-based PET probes.
引用
收藏
页码:1977 / 1984
页数:8
相关论文
共 27 条
[1]  
Artemov D, 2003, CANCER RES, V63, P2723
[2]   Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules [J].
Baum, Richard P. ;
Prasad, Vikas ;
Mueller, Dirk ;
Schuchardt, Christiane ;
Orlova, Anna ;
Wennborg, Anders ;
Tolmachev, Vladimir ;
Feldwisch, Joachim .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) :892-897
[3]   Small-animal PET Imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules [J].
Cheng, Zhen ;
De Jesus, Omayra Padilla ;
Namavari, Mohammad ;
De, Abhijit ;
Levi, Jelena ;
Webster, Jack Matt ;
Zhang, Rong ;
Lee, Brian ;
Syud, Faisal A. ;
Gambhir, Sanjiv Sam .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (05) :804-813
[4]   64Cu-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors [J].
Cheng, Zhen ;
De Jesus, Omayra Padilla ;
Kramer, Daniel J. ;
De, Abhijit ;
Webster, Jack M. ;
Gheysens, Olivier ;
Levi, Jelena ;
Namavari, Mohammad ;
Wang, Sen ;
Park, Jinha Mark ;
Zhang, Rong ;
Liu, Hongguang ;
Lee, Brian ;
Syud, Faisal A. ;
Gambhir, Sanjiv Sam .
MOLECULAR IMAGING AND BIOLOGY, 2010, 12 (03) :316-324
[5]   Structural basis for high-affinity HER2 receptor binding by an engineered protein [J].
Eigenbrot, Charles ;
Ultsch, Mark ;
Dubnovitsky, Anatoly ;
Abrahmsen, Lars ;
Hard, Torleif .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (34) :15039-15044
[6]   Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence [J].
Engfeldt, Torun ;
Orlova, Anna ;
Tran, Thuy ;
Bruskin, Alexander ;
Widstroem, Charles ;
Karlstroem, Amelie Eriksson ;
Tolmachev, Vladimir .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (05) :722-733
[7]   Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro [J].
Getmanova, Elena V. ;
Chen, Yan ;
Bloom, Laird ;
Gokemeijer, Jochem ;
Shamah, Steven ;
Warikoo, Veena ;
Wang, Jack ;
Ling, Vincent ;
Sun, Lin .
CHEMISTRY & BIOLOGY, 2006, 13 (05) :549-556
[8]   Biopharmaceutical drug discovery using novel protein scaffolds [J].
Gill, Davinder S. ;
Damle, Nitin K. .
CURRENT OPINION IN BIOTECHNOLOGY, 2006, 17 (06) :653-658
[9]   A Modular Platform for the Rapid Site-Specific Radiolabeling of Proteins with 18F Exemplified by Quantitative Positron Emission Tomography of Human Epidermal Growth Factor Receptor 2 [J].
Gill, Herman S. ;
Tinianow, Jeff N. ;
Ogasawara, Annie ;
Flores, Judith E. ;
Vanderbilt, Alexander N. ;
Raab, Helga ;
Scheer, Justin M. ;
Vandlen, Richard ;
Williains, Simon-P. ;
Marik, Jan .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (19) :5816-5825
[10]   Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells [J].
Hilger, I ;
Leistner, Y ;
Berndt, A ;
Fritsche, C ;
Haas, KM ;
Kosmehl, H ;
Kaiser, WA .
EUROPEAN RADIOLOGY, 2004, 14 (06) :1124-1129